Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02157493 · ClinicalTrials.gov registry record · NA

Evaluation of an Entrepreneurship Program for American-Indian Youth

A NA study of Substance Use and Depressive Symptoms, sponsored by Johns Hopkins Bloomberg School of Public Health.

Completed
Registry status
NA
Development phase
449
Enrollment target
1
Study location

NCT02157493: Completed NA study of Substance Use and Depressive Symptoms, sponsored by Johns Hopkins Bloomberg School of Public Health.

NCT02157493 is a NA study of Substance Use and Depressive Symptoms that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 449 participants, below the 1,255-participant average among 88 other Substance Use trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02157493, a NA study of Substance Use and Depressive Symptoms, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.

COMPLETED
Registry status
NA
Development phase
449 participants
Enrollment target
1
Study location

Study Summary

This study will use a randomized controlled design to evaluate whether a youth entrepreneurship/life-skills intervention for reservation-based American Indian adolescents (ages 13-15) improves psychosocial, behavioral health, educational, and economic outcomes from baseline for up to 3 years follow-up as compared to a recreational sports league control condition.

Interventions

  • BEHAVIORAL Arrowhead Business Group Curriculum
  • BEHAVIORAL Recreational League Control Condition

Study Locations (1)

Arizona

  • Johns Hopkins Center for American Indian Health - Whiteriver Office - Whiteriver

Trial Details

FieldValue
Enrollment Target 449 participants
Start Date 2014-04
Est. Completion 2019-06-25
Phase NA

What the finished NCT02157493 record still lists

NCT02157493 is an interventional study that assigns participants to a tested intervention. The registered 449 participants enrollment target is mid-sized for trials with a published cap, below the 1,255-participant average among 88 other Substance Use trials with a reported enrollment target (64% lower).

The record links to 2 conditions, with Substance Use appearing as the primary indexed condition, and to 2 interventions - of which Arrowhead Business Group Curriculum is the first listed.

NCT02157493 reports a single indexed study location in Arizona.

Frequently Asked Questions

What is clinical trial NCT02157493 about?

NCT02157493 is a clinical study titled "Evaluation of an Entrepreneurship Program for American-Indian Youth". This study will use a randomized controlled design to evaluate whether a youth entrepreneurship/life-skills intervention for reservation-based American Indian adolescents (ages 13-15) improves psychosocial, behavioral health, educational, and economic outcomes from baseline for up to 3 years follow-...

What is the current status of trial NCT02157493?

This trial is currently completed. It is a NA study. The enrollment target is 449 participants. The study started on 2014-04. Estimated completion is 2019-06-25.

What conditions does trial NCT02157493 study?

This clinical trial studies the following conditions: Substance Use, Depressive Symptoms.

What interventions are being tested in trial NCT02157493?

The interventions under investigation include: Arrowhead Business Group Curriculum (BEHAVIORAL), Recreational League Control Condition (BEHAVIORAL).

Who is sponsoring clinical trial NCT02157493?

This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02157493 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02157493's enrollment target sits among peer trials

449 22nd of 88 higher than 67 of 88 other Substance Use trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00515060 · 450 participants

    Psychophysical Studies of Cancer Therapy Pain

  • NCT01257269 · 450 participants

    Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

  • NCT03047161 · 450 participants

    Electrophysiology of Fetal Arrhythmia

  • NCT03269630 · 450 participants

    New Orleans Pulmonary Hypertension Biobank

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02157493, the US trial registry maintained by the National Library of Medicine. NCT02157493 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.